The Alliance of Community Health Plans (ACHP) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) about the National Coverage Determination (NCD) for beta amyloid pet scans in dementia and neurodegenerative disease patients.
With promising but uncertain treatments of Alzheimer’s actively in development, testing and early usage, now is not the appropriate time to change an NCD that has been in place and working since 2013.
New from ACHP:
- Overcoming Barriers: Transforming Black Maternal Health Through Research Webinar
- PODCAST: ACHP’s Ceci Connolly Joins Managed Healthcare Executive DC Roundtable Podcast
- OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
- ACHP Statement on Final Rule for Medicare Advantage and Part D
- WEBINAR: Medicare Advantage in 2024 and Beyond
- ACHP Joins First Lady Jill Biden and Health Care Leaders to Support Cancer Moonshot Initiative
